title: Human neutralizing antibodies against MERS coronavirus: implications for future immunotherapy.
authors.affiliation: Department of Cancer Immunology & AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
authors.forename: Xian-Chun
authors.initials: XC
authors.lastname: Tang
authors.affiliation: Department of Cancer Immunology & AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
authors.forename: Wayne A
authors.initials: WA
authors.lastname: Marasco
mesh_terms: D057134:Antibodies, Neutralizing / Q000276:immunology / Q000627:therapeutic use*; D000914:Antibodies, Viral / Q000276:immunology / Q000627:therapeutic use*; D018352:Coronavirus Infections / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy; D065207:Middle East Respiratory Syndrome Coronavirus / Q000276:immunology*; D011173:Portraits as Topic
chemical_list: D057134:Antibodies, Neutralizing; D000914:Antibodies, Viral
keywords: IGHV1–69; MERS-CoV; animal model; biodefense; emerging pathogen; human monoclonal antibodies; humoral immunity; passive immunotherapy; spike protein; zoonosis